Advertisement

Whitish Patches

  • Gulsen Akoglu
Chapter

Abstract

  • Wood light examination is a simple initial step to differentiate a variety of skin disorders including pigmentary disorders, bacterial and fungal cutaneous infections, as well as porphyria

  • Marginal inflammatory vitiligo (MIV) is a rare subset of vitiligo characterized by depigmented patches surrounded by a raised, erythematous border, usually associated with pruritus

  • The most commonly used drugs administered for children and adolescents with vitiligo are topical tacrolimus alone or combined with moderate to high potent topical corticosteroids, pimecrolimus, corticosteroids, and calcipotriol

Keywords

Wood light examination Marginal inflammatory vitiligo Topical tacrolimus Calcipotriol 

References

  1. 1.
    Asawanonda P, Taylor C. Wood’s light in dermatology. Review. Int J Dermatol. 1999;38(11):801–7.CrossRefGoogle Scholar
  2. 2.
    Gomez-Moyano E, Vera-Casaño A, Gamero A, Sanz-Trelles A, Crespo-Erchiga V. Inflammatory vitiligo or hypopigmented mycosis fungoides? J Pediatr Hematol Oncol. 2010;32(4):338–9.CrossRefGoogle Scholar
  3. 3.
    Ruocco E, Baroni A, Donnarumma G, Ruocco V. Diagnostic procedures in dermatology. Clin Dermatol. 2011;29(5):548–56.CrossRefGoogle Scholar
  4. 4.
    Verma S. Inflammatory vitiligo with raised borders and psoriasiform histopathology. Dermatol Online J. 2005;11(3):13.PubMedGoogle Scholar
  5. 5.
    Trikha R, McCowan N, Brodell R. Marginal vitiligo: an unusual depigmenting disorder. Dermatol Online J. 2014;21:3.Google Scholar
  6. 6.
    Gameiro A, Gouveia M, Tellechea Ó, Moreno A. Childhood hypopigmented mycosis fungoides: a commonly delayed diagnosis. BMJ Case Rep. 2014;2014:bcr2014208306.CrossRefGoogle Scholar
  7. 7.
    Turan E, Bagci IS, Erdemir AT, Gurel MS. Successful treatment of generalized discoid lupus erythematosus with imiquimod cream 5%: a case report and review of the literature. Acta Dermatovenerol Croat. 2014;22(2):150–9.PubMedGoogle Scholar
  8. 8.
    Chu H, Lee J, Lee Y, Kim D. Delayed treatment of generalized morphea due to misdiagnosis as vitiligo at an oriental medical clinic. Ann Dermatol. 2017;29(5):649–50.CrossRefGoogle Scholar
  9. 9.
    Annessi G, Paradisi M, Angelo C, Perez M, Puddu P, Girolomoni G. Annular lichenoid dermatitis of youth. J Am Acad Dermatol. 2003;49(6):1029–36.CrossRefGoogle Scholar
  10. 10.
    Phiske M. Vitiligo in children: a birds eye view. Curr Pediatr Rev. 2016;12(1):55–66.CrossRefGoogle Scholar
  11. 11.
    Menezes AD, Carvalho FO, Barreto R, Silva BS, Shanmugam S, Gurgel R, Araújo AS. Pharmacologic treatment of vitiligo in children and adolescents: a systematic review. Pediatr Dermatol. 2017;34(1):13–24.CrossRefGoogle Scholar
  12. 12.
    Taïeb A, Seneschal J, Mazereeuw-Hautier J. Special considerations in children with vitiligo. Dermatol Clin. 2017;35(2):229–33.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Gulsen Akoglu
    • 1
  1. 1.Gulhane Training and Research Hospital, Dermatology and Venereology ClinicUniversity of Health SciencesAnkaraTurkey

Personalised recommendations